Thursday, April 23, 2020 6:02:27 PM
I find your posts very informative. I just joined the AGN party a couple days ago and I have no medical background and I'm trying to educate myself... specifically I'm trying to understand why it is important that NP120 is a NMDA Glu2NB antagonist... google searches don't reveal anything about NMDA and COVID19 (other than articles related to Ifenprodil). Is NMDA a consequence of the body's autoimmune response to the virus, and high levels of NMDA contribute to the cytokine storm that is so damaging? Can you also please explain what the relevance of Ifenprodil's antagonist activity against the Sigma-1 receptor with respect to COVID19?
Thanks!!!
Thanks!!!
Recent AGNPF News
- Grey Matters Announces Private Placement • GlobeNewswire Inc. • 04/22/2026 11:00:00 AM
- Algernon Health Announces Effective Date of Previously Announced Name Change to “Grey Matters Health Inc.” and its 10:1 Share Consolidation • GlobeNewswire Inc. • 04/15/2026 08:01:00 PM
- Algernon Health Announces Proposed Name Change to “Grey Matters Health Inc.” and a 10:1 Share Consolidation • GlobeNewswire Inc. • 03/31/2026 11:09:55 PM
- Algernon Health Announces NOVASCAN NEUROIMAGING CLINICS™ as the New Brand Name for its U.S. Brain PET Scanning Centers • GlobeNewswire Inc. • 03/25/2026 11:00:00 AM
- Algernon to Open the First Brain Dedicated PET Scanning Clinic in the U.S. at the HCA Florida University Medical Office Building • GlobeNewswire Inc. • 03/23/2026 11:00:00 AM
- Algernon Announces Additional Increase to Private Placement Financing to $858,000 and Final Closing of the Financing • GlobeNewswire Inc. • 12/31/2025 09:01:00 PM
- Algernon Announces Increase to Private Placement Financing to $750,000 and Close of Third Tranche • GlobeNewswire Inc. • 12/23/2025 09:01:00 PM
- Form D/A - Notice of Exempt Offering of Securities: [Amend] • Edgar (US Regulatory) • 12/09/2025 05:01:20 PM
- Algernon Closes Second Tranche of Private Placement Financing • GlobeNewswire Inc. • 11/29/2025 12:51:39 AM
- Algernon Health and American Molecular Imaging Announce Strategic Business and USD $500K Investment Agreement • GlobeNewswire Inc. • 11/17/2025 12:00:00 PM
- Algernon Closes First Tranche of its Recently Announced Private Placement Financing • GlobeNewswire Inc. • 11/15/2025 12:55:26 AM
- Algernon Health Announces Private Placement • GlobeNewswire Inc. • 11/06/2025 12:04:28 PM
- Algernon Pharmaceuticals Completes Name Change to Algernon Health • GlobeNewswire Inc. • 10/15/2025 11:00:00 AM
- Algernon Announces CAD $4 Million Non-Dilutive Financing to Open Four Brain-Specific PET Scan Clinics in the U.S. for Early Stage Alzheimer’s Detection • GlobeNewswire Inc. • 09/25/2025 11:00:00 AM
- Algernon Announces Preferred Share Class Approved at Annual and Special Meeting • GlobeNewswire Inc. • 09/19/2025 08:39:57 PM
